Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ

Background: Diabetic cardiomyopathy is the primary complication associated with diabetes mellitus and also is a major cause of death and disability. Limited pharmacological therapies are available for diabetic cardiomyopathy. Qiliqiangxin (QLQX), a Chinese medication, has been proven to be beneficia...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xiaodong Wu, Ting Zhang, Ping Lyu, Mengli Chen, Gehui Ni, Huiling Cheng, Guie Xu, Xinli Li, Lijun Wang, Hongcai Shang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-07-01
coleção:	Frontiers in Cardiovascular Medicine
Assuntos:	Qiliqiangxin diabetic cardiomyopathy apoptosis fibrosis PPARγ PGC-1α
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fcvm.2021.698056/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!